Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.60 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.58 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.58 |
| ▸ | TUBB | P07437 | 1/20 | 0.58 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.58 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.58 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.58 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.58 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.58 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.58 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.58 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.58 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.58 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.58 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30625282 | 1.00 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL1301189 | 1.00 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL1301186 | 1.00 | CYP1A1 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL2679429 | 0.90 | PTGS1 (0.54) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| Malonic Acid SCHEMBL27751245 | 0.89 | NFE2L2 (0.61) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL4686225 | 0.87 | TUBB1 (0.56) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL4686223 | 0.87 | TUBB1 (0.56) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL6587547 | 0.87 | MMP9 (0.58) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL6587536 | 0.87 | MMP9 (0.58) | CYP1A1PTGS1PTGS2NFE2L2CYP1B1 | |
| SCHEMBL4631918 | 0.86 | KDM4E (0.67) | PTGS1TUBB1TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1071440-B1 | NOVEL SYNERGISTIC COMPOSITIONS CONTAINING AROMATIC COMPOUNDS AND TERPENOIDS PRESENT IN ALPINIA GALANGA | EUROVITA AS (DK) | 2007-01-03 | — | — | EP | claimed |
| CN-1125651-C | Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga | OVEDA AS (DK) | 2003-10-29 | — | — | CN | claimed |
| US-20030157204-A1 | Novel synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga | ENROVITA A/S | 2003-08-21 | — | — | US | claimed |
| US-6566405-B2 | Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics | EUROVITA A/S (DK) | 2003-05-20 | — | — | US | claimed |
| US-20020086906-A1 | NOVEL SYNERGISTIC COMPOSITIONS CONTAINING AROMATIC COMPOUNDS AND TERPENOIDS PRESENT IN ALPINIA GALANGA | ASTION DEVELOPMENT A/S (DK) | 2002-07-04 | — | — | US | claimed |
| CN-1303295-A | Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga | IDA DEV AS (DK) | 2001-07-11 | — | — | CN | claimed |
| EP-1071440-A1 | NOVEL SYNERGISTIC COMPOSITIONS CONTAINING AROMATIC COMPOUNDS AND TERPENOIDS PRESENT IN ALPINIA GALANGA | Ida Development A/S (DK) | 2001-01-31 | — | — | EP | claimed |
| WO-1999053935-A1 | NOVEL SYNERGISTIC COMPOSITIONS CONTAINING AROMATIC COMPOUNDS AND TERPENOIDS PRESENT IN ALPINIA GALANGA | IDA DEVELOPMENT A/S (DK) | 1999-10-28 | — | — | WO | claimed |
| WO-2025075465-A1 | NOVEL COMPOUND DERIVED FROM MYRISTICA FRAGRANS, AND ANTICANCER COMPOSITION COMPRISING SAME | 한국과학기술연구원 | 2025-04-10 | — | — | WO | disclosed |
| WO-2023131362-A1 | PHENYLPROPANOID DERIVATIVES | USTAV EXPERIMENTALNI BOTANIKY AV ČR, V. V. I. (CZ) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023131362-A1 | PHENYLPROPANOID DERIVATIVES | USTAV EXPERIMENTALNI BOTANIKY AV ČR, V. V. I. (CZ) | 2023-07-13 | — | — | WO | disclosed |
| WO-2019172013-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | 住友化学株式会社 | 2019-09-12 | — | — | WO | disclosed |
| US-10202410-B2 | Scaphopetalone analogs and their uses | BRIGHAM YOUNG UNIVERSITY (US) | 2019-02-12 | — | — | US | disclosed |
| US-10202410-B2 | Scaphopetalone analogs and their uses | BRIGHAM YOUNG UNIVERSITY (US) | 2019-02-12 | — | — | US | disclosed |
| US-4948796-A | TREATING CEREBO-VASCULARE DISEASES | TOYAMA CHEMICAL CO., LTD. (JP) | 1990-08-14 | — | — | US | disclosed |
| EP-0273678-A2 | Aromatic derivative and preparation method thereof | TEIJIN LIMITED (JP) | 1988-07-06 | — | — | EP | disclosed |
| US-4704462-A | PLATELET-ACTIVATING FACTOR | MERCK & CO., INC. (US) | 1987-11-03 | — | — | US | disclosed |
| US-4687727-A | Light-sensitive planographic printing plate with layer of diazo resin containing photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1987-08-18 | — | — | US | disclosed |
| US-4511645-A | ALLYL METHACRYLATE-METHACRYLIC ACID COPOLYMER, CURING AGENT, PHOTOINITIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1985-04-16 | — | — | US | disclosed |
| EP-0104863-A2 | Light-sensitive planographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1984-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10202410-B2 | Scaphopetalone analogs and their uses | MUSK, SHBG, CYP17A1 | CYP1A1 3286/4885PTGS1 2251/4885PTGS2 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.